Showing results (1-10 of 203) with videos related to
Sort By:
Pageof 21
Journal of Molecular Neuroscience : MN|January 1, 1993
Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide geneI Gozes, J Glowa, D E Brenneman, et al.Molecular Neurobiology|January 1, 1989
VIP: molecular biology and neurobiological functionI Gozes, D E BrennemanJournal of Molecular Neuroscience : MN|January 1, 1993
Neuropeptides as growth and differentiation factors in general and VIP in particularI Gozes, D E BrennemanJournal of Molecular Neuroscience : MN|January 1, 1996
Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin?I Gozes, D E BrennemanJournal of Molecular Neuroscience : MN|June 15, 2000
A new concept in the pharmacology of neuroprotectionI Gozes, D E BrennemanThe Journal of Clinical Investigation|May 15, 1996
A femtomolar-acting neuroprotective peptideD E Brenneman, I GozesThe Journal of Pharmacology and Experimental Therapeutics|June 1, 1991
An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous systemI Gozes, S K McCune, L Jacobson, et al.Cellular and Molecular Neurobiology|December 1, 1995
A VIP hybrid antagonist: from developmental neurobiology to clinical applicationsI Gozes, M Fridkin, D E BrennemanBiochemical Society Transactions|August 30, 2000
Protective peptides derived from novel glial proteinsD E Brenneman, C Y Spong, I GozesJournal of Molecular Neuroscience : MN|April 17, 2001
VIP-Related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells: a model for ischemic/hypoxic injuryE Sigalov, M Fridkin, D E Brenneman, et al.Pageof 21